Home
Technologies
Live Cell Encapsulation
Research & Development
Cancer
Diabetes
Cannabinoids
Company
Management
Board of Directors
Governance
Medical and Scientific Advisory Board
International Diabetes Consortium
Investor Relations
Overview
News / Events
Shareholder Calls / Presentations
Company Information
Financial Information
Stock Data
SEC Filings
Corporate Governance
News
Press Releases
Articles
Reports
Media
Photo Gallery
Contact
Home
Technologies
– Live Cell Encapsulation
– Research & Development
– Cancer
– Diabetes
– Cannabinoids
Company
– Management
– Board of Directors
– Governance
– Medical and Scientific Advisory Board
– International Diabetes Consortium
Investor Relations
– Overview
– News / Events
– Company Information
– Financial Information
– Stock Data
– SEC Filings
– Corporate Governance
News
– Press Releases
– Articles
– Reports
– Media
– Photo Gallery
Contact
All SEC Filings
Navigation Toggle
Navigation
Overview
News / Events
Shareholder Calls / Presentations
Company Information
Financial Information
Stock Data
SEC Filings
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Corporate Governance
Quick Links
Email Alerts
Tear Sheet
Contacts
RSS News Feed
Filter Filings:
View All
10-K
10-K/A
10-Q
10-Q/A
10KSB
10KSB/A
10QSB
10QSB/A
3
424B2
424B3
424B5
425
8-K
8-K/A
CORRESP
CT ORDER
D
EFFECT
NT 10-K
NT 10-Q
NTN 10K
NTN 10Q
S-3
S-3/A
S-8
S-8 POS
SB-2
SB-2/A
SC 13D
SC 13D/A
UPLOAD
Date
Form
Description
Docs
XBRL
Pages
08/04/14
10-K
Annual report pursuant to Section 13 and 15(d)
Related Documents
EX-10.1
EX-10.2
EX-10.4
EX-10.4
EX-10.6
EX-10.7
EX-10.9
EX-10.10
EX-21.1
EX-31.1
EX-31.2
EX-32.1
EX-32.2
165
07/30/14
NT 10-K
Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10-KT
2
07/11/14
CORRESP
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
15
06/30/14
UPLOAD
SEC-generated letter
5
05/29/14
8-K
Current report filing
Related Documents
EX-4.1
EX-10.1
EX-99.1
42
05/27/14
CORRESP
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
20
05/05/14
CORRESP
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
1
05/02/14
CORRESP
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
1
04/24/14
UPLOAD
SEC-generated letter
4
03/25/14
8-K
Current report filing
Related Documents
EX-10.1
4
<< Previous
1...
5
6
7
8
9
10
11
12
13
14
...27
Next >>